Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (10): 952-954.DOI: 10.3969/j.issn.1673-8640.2022.010.009
Previous Articles Next Articles
Received:
2020-12-17
Revised:
2021-12-16
Online:
2022-10-30
Published:
2022-11-14
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.010.009
项目 | β值 | 标准误 | Wald值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
胆道系统感染 | 0.98 | 0.38 | 6.58 | 0.001 | 2.32 | 1.26~4.26 |
胆胰疾病史 | 0.68 | 0.48 | 1.96 | <0.001 | 4.26 | 2.30~7.91 |
胆道手术史 | 1.44 | 0.56 | 6.74 | <0.001 | 5.51 | 2.77~10.93 |
年龄 | 0.03 | 0.01 | 9.82 | 0.002 | 1.04 | 1.01~1.06 |
项目 | β值 | 标准误 | Wald值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
胆道系统感染 | 0.98 | 0.38 | 6.58 | 0.001 | 2.32 | 1.26~4.26 |
胆胰疾病史 | 0.68 | 0.48 | 1.96 | <0.001 | 4.26 | 2.30~7.91 |
胆道手术史 | 1.44 | 0.56 | 6.74 | <0.001 | 5.51 | 2.77~10.93 |
年龄 | 0.03 | 0.01 | 9.82 | 0.002 | 1.04 | 1.01~1.06 |
病原菌名称 | 菌株数/株 | 构成比/% |
---|---|---|
革兰阴性菌 | ||
大肠埃希菌 | 44 | 51.8 |
肺炎克雷伯菌 | 12 | 14.1 |
阴沟肠杆菌 | 5 | 5.9 |
铜绿假单胞菌 | 2 | 2.4 |
产气肠杆菌 | 2 | 2.4 |
嗜水气单胞菌群 | 2 | 2.4 |
丙二酸盐阴性柠檬酸菌 | 2 | 2.4 |
产酸克雷伯菌 | 1 | 1.2 |
中间型肠杆菌 | 1 | 1.2 |
普通变形杆菌 | 1 | 1.2 |
奇异变形杆菌 | 1 | 1.2 |
鲍曼不动杆菌 | 1 | 1.2 |
斯氏假单胞菌 | 1 | 1.2 |
革兰阳性菌 | ||
粪肠球菌 | 3 | 3.5 |
铅黄肠球菌 | 2 | 2.4 |
鹑鸡肠球菌 | 1 | 1.2 |
缓症链球菌 | 1 | 1.2 |
乳酸乳酸球菌 | 1 | 1.2 |
瓦氏葡萄球菌 | 1 | 1.2 |
真菌 | ||
白念珠菌 | 1 | 1.2 |
病原菌名称 | 菌株数/株 | 构成比/% |
---|---|---|
革兰阴性菌 | ||
大肠埃希菌 | 44 | 51.8 |
肺炎克雷伯菌 | 12 | 14.1 |
阴沟肠杆菌 | 5 | 5.9 |
铜绿假单胞菌 | 2 | 2.4 |
产气肠杆菌 | 2 | 2.4 |
嗜水气单胞菌群 | 2 | 2.4 |
丙二酸盐阴性柠檬酸菌 | 2 | 2.4 |
产酸克雷伯菌 | 1 | 1.2 |
中间型肠杆菌 | 1 | 1.2 |
普通变形杆菌 | 1 | 1.2 |
奇异变形杆菌 | 1 | 1.2 |
鲍曼不动杆菌 | 1 | 1.2 |
斯氏假单胞菌 | 1 | 1.2 |
革兰阳性菌 | ||
粪肠球菌 | 3 | 3.5 |
铅黄肠球菌 | 2 | 2.4 |
鹑鸡肠球菌 | 1 | 1.2 |
缓症链球菌 | 1 | 1.2 |
乳酸乳酸球菌 | 1 | 1.2 |
瓦氏葡萄球菌 | 1 | 1.2 |
真菌 | ||
白念珠菌 | 1 | 1.2 |
[1] |
YOKOE M, HATA J, TAKADA T, et al. Tokyo Guidelines 2018:diagnostic criteria and severity grading of acute cholecystitis(with videos)[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1):41-54.
DOI URL |
[2] | 尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2015. |
[3] | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-S31,CLSI, 2021. |
[4] |
SUNG J Y, COSTERTON J W, SHAFFER E A. Defense system in the biliary tract against bacterial infection[J]. Dig Dis Sci, 1992, 37(5):689-696.
DOI URL |
[5] | 林艳. 胆道疾病内镜逆行胰胆管造影术中胆汁病原菌培养及药敏分析[D]. 南宁: 广西医科大学, 2012. |
[6] |
CHANDRA S, KLAIR J S, SOOTA K, et al. Endoscopic retrograde cholangio-pancreatography-obtained bile culture can guide antibiotic therapy in acute cholangitis[J]. Dig Dis, 2019, 37(2):155-160.
DOI PMID |
[7] | 吴自友, 吴向嵩, 姚文衍, 等. 急性胆道感染患者胆汁病原菌分布及耐药率变迁[J]. 中华外科杂志, 2021, 59(1):24-31. |
[8] | 全国细菌耐药监测网2014—2019年胆汁细菌耐药监测报告[J]. 中国感染控制杂志, 2021, 20(1):77-85. |
[9] |
YANG Q, WANG H, CHEN M, et al. Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China:the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART)[J]. Int J Antimicrob Agents, 2010, 36(6):507-512.
DOI URL |
[10] | 李静, 吴广利, 牛琼, 等. 梗阻性黄疸患者胆汁病原菌培养及药敏分析[J]. 中国内镜杂志, 2018, 24(2):94-99. |
[11] | 黄会, 吴多荣, 张罡. 487例胆汁培养病原菌构成及耐药性分析[J]. 实用预防医学, 2015, 22(5):615-617. |
[12] |
COCCOLINI F, SARTELLI M, CATENA F, et al. Antibiotic resistance pattern and clinical outcomes in acute cholecystitis:567 consecutive worldwide patients in a prospective cohort study[J]. Int J Surg, 2015, 21:32-37.
DOI URL |
[13] | REUKEN P A, TORRES D, BAIER M, et al. Risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis[J]. PLoS One, 2017, 12(1):e0169900. |
[14] |
KWON J S, HAN J, KIM T W, et al. Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years[J]. Korean J Gastroenterol, 2014, 63(5):299-307.
PMID |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||